Inventors:
Jennifer R. Allen - Newbury Park CA, US
Biswas Kaustav - Agoura Hills CA, US
Frank Chavez - Camarillo CA, US
Ning Chen - Thousand Oaks CA, US
Frenel Fils De Morin - Thousand Oaks CA, US
James R. Falsey - Moorpark CA, US
Michael J. Frohn - Thousand Oaks CA, US
Paul E. Harrington - Camarillo CA, US
Daniel B. Horne - Simi Valley CA, US
Essa Hu Harrington - Camarillo CA, US
Matthew R. Kaller - Ventura CA, US
Roxanne Kunz - Santa Monica CA, US
Holger Monenschein - Jupiter FL, US
Thomas T. Nguyen - Newbury Park CA, US
Alexander J. Pickrell - Westlake Village CA, US
Andreas Reichelt - Moorpark CA, US
Shannon Rumfelt - Camarillo CA, US
Robert M. Rzasa - Ventura CA, US
Kelvin Sham - Thousand Oaks CA, US
Guomin Yao - Camarillo CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/4439
A61K 31/437
A61K 31/52
A61K 31/5377
A61K 31/55
A61K 31/397
C07D 401/12
C07D 471/04
C07D 473/00
C07D 413/14
C07D 401/14
A61P 25/00
US Classification:
51421021, 514303, 514338, 51426322, 5142358, 51421208, 5462734, 546118, 544277, 544131
Abstract:
Pyridine and pyrimidine compounds, and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.